Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

Nagahara, Alan H.; Merrill, David A.; Coppola, Giovanni; Tsukada, Shingo; Schroeder, Brock E.; Shaked, Gideon M.; Ling Wang; Blesch, Armin; Kim, Albert; Conner, James M.; Rockenstein, Edward; Chao, Moses V.; Koo, Edward H.; Geschwind, Daniel; Masliah, Eliezer; Chiba, Andrea A.; Tuszynski, Mark H.
March 2009
Nature Medicine;Mar2009, Vol. 15 Issue 3, p331
Academic Journal
Profound neuronal dysfunction in the entorhinal cortex contributes to early loss of short-term memory in Alzheimer's disease. Here we show broad neuroprotective effects of entorhinal brain-derived neurotrophic factor (BDNF) administration in several animal models of Alzheimer's disease, with extension of therapeutic benefits into the degenerating hippocampus. In amyloid-transgenic mice, BDNF gene delivery, when administered after disease onset, reverses synapse loss, partially normalizes aberrant gene expression, improves cell signaling and restores learning and memory. These outcomes occur independently of effects on amyloid plaque load. In aged rats, BDNF infusion reverses cognitive decline, improves age-related perturbations in gene expression and restores cell signaling. In adult rats and primates, BDNF prevents lesion-induced death of entorhinal cortical neurons. In aged primates, BDNF reverses neuronal atrophy and ameliorates age-related cognitive impairment. Collectively, these findings indicate that BDNF exerts substantial protective effects on crucial neuronal circuitry involved in Alzheimer's disease, acting through amyloid-independent mechanisms. BDNF therapeutic delivery merits exploration as a potential therapy for Alzheimer's disease.


Related Articles

  • Remember rolipram?  // Journal of Clinical Investigation;Dec2004, Vol. 114 Issue 11, p1527 

    This article presents information on research related to Alzheimer disease (AD) which is a progressive neurodegenerative disorder characterized by mild cognitive impairment due to increased levels of amyloid β-peptides followed by deficits in multiple cortical functions in later stages of...

  • Gene expression analysis in the lung of the rasH2 transgenic mouse at week 4 prior to induction of malignant tumor formation by urethane and N-methylolacrylamide. Satoshi Tsuji; Yusuke Kuwahara; Hironori Takagi; Masayuki Sugiura; Yutaka Nakanishi; Masaki Wakamatsu; Katsuki Tsuritani; Yasushi Sato // Journal of Toxicological Sciences;Nov2015, Vol. 40 Issue 6, p685 

    The rasH2 transgenic (Tg) mice are susceptible to genotoxic and some non-genotoxic carcinogens. In carcinogenicity studies carried out using rasH2 Tg mice, the carcinogenic potential of chemicals are evaluated over a 26-week experimental period. In the present study, we examined the...

  • Natural Animal Models of Neurodegenerative Protein Misfolding Diseases. Moreno-Gonzalez, Ines; Soto, Claudio // Current Pharmaceutical Design;3/11/2012, Vol. 18 Issue 8, p1148 

    Neurodegenerative diseases (NDs) are some of the most debilitating human illnesses. Research over the past 10 years has provided evidence for a common mechanism of neurodegeneration in which the critical event is the brain accumulation of misfolded protein aggregates. Although it is well...

  • The Functional Upregulation of Piriform Cortex Is Associated with Cross- Modal Plasticity in Loss of Whisker Tactile Inputs. Bing Ye; Li Huang; Zilong Gao; Ping Chen; Hong Ni; Sudong Guan; Yan Zhu; Jin-Hui Wang; Mei, Lin // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Background: Cross-modal plasticity is characterized as the hypersensitivity of remaining modalities after a sensory function is lost in rodents, which ensures their awareness to environmental changes. Cellular and molecular mechanisms underlying cross-modal sensory plasticity remain unclear. ...

  • Alzheimer's disease: experimental models and reality. Drummond, Eleanor; Wisniewski, Thomas // Acta Neuropathologica;Feb2017, Vol. 133 Issue 2, p155 

    Experimental models of Alzheimer's disease (AD) are critical to gaining a better understanding of pathogenesis and to assess the potential of novel therapeutic approaches. The most commonly used experimental animal models are transgenic mice that overexpress human genes associated with familial...

  • KISS1 expression in human female adipose tissue. Cockwell, Heather; Wilkinson, Diane; Bouzayen, Renda; Imran, Syed; Brown, Russell; Wilkinson, Michael // Archives of Gynecology & Obstetrics;Jan2013, Vol. 287 Issue 1, p143 

    Objective: The current focus of kisspeptin research is an exploration of its key role in the hypothalamic control of human and animal fertility. Notwithstanding the importance of these studies, strong evidence exists that the gene encoding human kisspeptin, KISS1, is present in several...

  • The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1. Roybon, Laurent; Mastracci, Teresa L.; Li, Joyce; Stott, Simon R. W.; Leiter, Andrew B.; Sussel, Lori; Brundin, Patrik; Li, Jia-Yi // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Production of olfactory bulb neurons occurs continuously in the rodent brain. Little is known, however, about cellular diversity in the glutamatergic neuron subpopulation. In the central nervous system, the basic helix-loop-helix transcription factor NeuroD1 (ND1) is commonly associated with...

  • Ctip2-, Satb2-, Prox1-, and GAD65-Expressing Neurons in Rat Cultures: Preponderance of Single- and Double-Positive Cells, and Cell Type-Specific Expression of Neuron-Specific Gene Family Members, Nsg-1 (NEEP21) and Nsg-2 (P19). Digilio, Laura; Yap, Chan Choo; Winckler, Bettina // PLoS ONE;10/14/2015, Vol. 10 Issue 10, p1 

    The brain consists of many distinct neuronal cell types, but which cell types are present in widely used primary cultures of embryonic rodent brain is often not known. We characterized how abundantly four cell type markers (Ctip2, Satb2, Prox1, GAD65) were represented in cultured rat neurons,...

  • Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. Gong, Bing; Vitolo, Ottavio V.; Trinchese, Fabrizio; Liu, Shumin; Shelanski, Michael; Arancio, Ottavio // Journal of Clinical Investigation;Dec2004, Vol. 114 Issue 11, p1624 

    Evidence suggests that Alzheimer disease (AD) begins as a disorder of synaptic function, caused in part by increased levels of amyloid β-peptide 1-42 (Aβ42). Both synaptic and cognitive deficits are reproduced in mice double transgenic for amyloid precursor protein (AA substitution...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics